Dr. Anita Gupta, Adjunct assistant professor of anesthesiology and critical care medicine at the Johns Hopkins University School of Medicine, joins Cheddar Reveals to share her forecast for the healthcare industry in 2022.
Waseem Asghar, Ph.D., Associate Professor, Department of Computer & Electrical Engineering and Computer Science, Florida Atlantic University, joins Cheddar Reveals to break down the latest progress, trends, and innovations in wearable health tech.
Washington DC and the surrounding areas saw a record breaking snow storm Monday as a strong storm system works its way across the eastern U.S. The extreme weather event caused extensive damage in the greater Washington area, leaving thousands in the region without power. Jonathan Porter, Chief Meteorologist, AccuWeather, joined Wake Up with Cheddar to discuss the fierce storm.
Sweta Chakraborty, U.S. President of We Don't Have Time and climate change expert, joins Cheddar News to discuss how mining the proper resources for the clean energy sector is crucial.
Over the past year alone, we've seen an increasing push-back on fossil fuels, legislation to reduce plastic pollution, greater protection over our worlds' forests, and a growing number of companies working to reduce total carbon footprint. To discuss the sustainability trends that defined 2021 and the changes individuals can make in 2022, J.D. Durkin is joined by Ashlee Piper, a sustainability expert and author of 'Give a Sh*t: Do Good. Live Better. Save the Planet,' joins Cheddar News.
Experts say that at some point next year, the pandemic will officially drop its pandemic status, becoming endemic. While this is a milestone to acknowledge, it does not mean we're free of infections, illnesses, and deaths. Dr. Rajeev Fernando, infectious disease specialist, Beth Israel Hospital and fellow, joins Cheddar News' Closing Bell to discuss.
Chicago-based Internist Dr. Vivek Cherian joined Wake Up With Cheddar to break down the unprecedented surge in U.S. COVID-19 as many prepare to celebrate the new year.
Dr. Soumi Eachempati, co-founder and CEO of Cleared4 and former professor of surgery and public health at Weill Cornell Medical College, joined Cheddar to breakdown what people should know about the recently FDA-approved emergency use of Merck and Pfizer's COVID-19 treatment pills. He noted that not only do people need to be aware of other medications they are taking that could cause adverse effects if coupled with COVID-19 pill treatments, he also talked about the intense in-take regiment. "The Merck pills are actually about 40 pills over five days. The Pfizer ones are three pills over five days, so people have to be prepared for that because it is a lot of pills you'll have to take to get full value from these drugs," Eachempati told Cheddar.